TC BIOPHARM HOLDINGS PLC-ADR (TCBP) Stock Analyst Earnings Estimates
NASDAQ:TCBP - Nasdaq - US87807D5095 - ADR
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.98M -42.27% | 1.98M | 3.84M 93.94% | 2.018M -100.00% | |||
| EBITDA YoY % growth | -5.82M -2.46% | -6.29M -8.08% | -10.95M -74.09% | N/A -24.26% | N/A | N/A | |
| EBIT YoY % growth | -6.89M -4.71% | -7.31M -6.10% | -11.92M -63.06% | -24.094M -19.46% | -13.813M 3.00% | -14.484M -4.86% | |
| Operating Margin | -347.98% | -369.19% | -310.42% | -1,193.98% | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | -4.69 99.80% | -0.01 99.78% | 0.00 100.00% |
All data in GBP
| Q3 / 23 | Q4 / 23 | Q1 / 24 | |
|---|---|---|---|
| EPS Q2Q % growth | -0.81 99.93% | -0.71 99.94% | N/A |
| Revenue Q2Q % growth | 504.9K | 504.9K -86.87% | N/A |
| EBITDA Q2Q % growth | N/A | N/A | N/A |
| EBIT Q2Q % growth | -5.514M -8.01% | -5.616M 52.89% | N/A |
All data in GBP
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q4 2022 Q2Q % growth | 3.845M 684.60% | 504.9K | 3.34M | 661.44% |
| Q3 2022 Q2Q % growth | 3.04% | 504.9K | % | |
| Q2 2022 Q2Q % growth | 989K -0.03% | % | ||
| Q4 2021 Q2Q % growth | 490K | % | ||
| Q3 2021 Q2Q % growth | 490K | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 0% | 0% | N/A |
| Revenue | 0% | 0% | N/A | N/A |